
    
      The researchers wish to investigate the use of physostigmine in the elderly patients (age >
      60 yrs, ASA I-III) in the postoperative recovery-phase after general anesthesia.

      Apart from the beneficial effects for the patient, the lessened amount of time in the PACU
      will release caregiving resources and thereby increase the efficacy of the PACU.
    
  